and recurrent miscarriage (RM) is less clear-cut and much more controversial. Although 35% of one series of RM patients The presence of anti-cardiolipin antibodies (aCL) in women were found to have these antibodies (Unander et al., 1987), is an established risk factor for fetal loss, but these autoantimost studies of such patients report a prevalence of 2-10% bodies had not previously been investigated in the male for IgG antibodies provided a sensible definition of positivity partners of recurrent aborters. The prevalence of aCL in is used. The largest series reported a value of 3.3% (Rai et al., 144 male partners of couples with a history of recurrent 1995). The reported normal prevalence is also rather variable, miscarriage was 4.2%, which compares with 2.8% for 177
and 20 GPL were provisionally deemed borderline, and re-tested. If Table I . Anti-cardiolipin antibodies in patients and controls similar results were not obtained on re-testing, the sera were subsequently assayed until consistent results were obtained. On this Range Median No (%) No (%) basis, sera consistently yielding values between 15 and 20 GPL were (GPL) (GPL) positive borderline finally deemed 'borderline', and all those Ͻ15 GPL deemed negative.
(Ͼ20 GPL) (15) (16) (17) (18) (19) (20) RM men (n ϭ 144) 2.0-46 7.7 6 (4.2) 3 (2)
Patients and controls
RM women (n ϭ 177) 0.6-358 4.9 5 (2.8) 5 (2.8) Recurrent miscarriage is defined as three or more consecutive spontanPostnatal controls (n ϭ 74) 0.1-9.9 3.1 0 0 eous abortions with the same reproductive partner irrespective of live Blood donors (n ϭ 254) 1.6-77 6.6 15 (5.9) 13 (5.1) births achieved with the same or former partners. Sera were obtained GPL ϭ IgG-phospholipid antibody units.
from 177 female patients (median age 31 years; range 21-43) and from 144 male partners (median age 34 years; range 18-55) of those patients. The medical backgrounds of the male partners were These figures are in marked contrast to the corresponding data from couples where the female partners have high Results cardiolipin antibody values. The median number of previous miscarriages at presentation was four (mean 4.5). Four out of In all, 4.2% of the male partners in RM couples were found to be positive for cardiolipin antibodies. This was a slightly five aCL-positive women presented with more than three previous miscarriages; although this relationship just failed to higher proportion than for their wives, and slightly lower than for the population of blood donors. There were no differences reach statistical significance, inclusion of the borderline cases did achieve statistical significance (P ϭ 0.007 compared to in cardiolipin antibody values between male and female blood donors, nor across the age range of the blood donors. The antibody negative couples, by Fisher's exact test). Three of those positive for aCL conceived again after presentation; two occurrence of borderline results was also similar in the blood donor group and the RM males and females. No positive or aborted in the first trimester and the other was delivered of a live baby at 31 weeks. One of the borderline cases also borderline results were obtained with the obstetrically normal postnatal control group, and their cardiolipin antibody values conceived again and miscarried again after presentation. Sera from only two male partners with positive aCL were were generally lower (Table I) .
Some characteristics of the antibody positive and borderline obtained 3 and 4 months apart respectively, but in both cases similar positive results were obtained on both occasions. From male partners are listed in Table II . A high proportion had the HLA-DR53-associated specificities, DR4 and DR7. This was the women with positive aCL, in most cases serial samples were available ranging from 1 month to 5 years apart, and in contrast to the female patients with cardiolipin antibodies, where no relationship with any HLA-DR specificity could be showed only minor fluctuations in activity. The samples from RM couples were also assayed for aCL demonstrated (data not given).
The number of miscarriages (median 3; mean 3.4) reported under identical conditions except for a direct comparison of phosphatidylserine with untreated FCS, shifting to a greater This is the first report of the surprising observation that aCL occur just as often in the male partners of couples experiencing aCL positive or borderline sera from male partners were re-assayed either as recurrent miscarriage as in the women patients themselves, before (no treatment) or using fetal calf serum which had been incubated at 56°C for 30 min before use (heat treatment). Otherwise the assay conditions and are no more prevalent than in the general (obstetrically were the same.
non-selected) healthy population represented by blood donors.
No positive or even borderline results were obtained from the obstetrically selected postnatal control group. Women in late Introduction. There can be no question that aCL constitute a and 0.9 or less respectively. The analysis was also performed on the same major risk factor in pregnancy, but the implication of this sera assayed using heat-treated FCS, and the numbers in each category given in parentheses.
work is that it may be inappropriate to restrict investigation of aCL to women who have repeatedly miscarried. Instead, our data strengthen the case for antenatal screening of the untreated and heat-treated (56°C for 30 min) fetal calf serum entire obstetric population without prior selection (Kilpatrick, to block the plates and to add to the diluent. When heat-treated 1994). The question of general antenatal screening is controver-FCS was used, only two of the six positive male sera sial, however, and the cost-effectiveness of such a proposal remained positive and the three borderline sera became negative would depend on the effectiveness of clinical intervention (Table III) . The effect of using heat-treated FCS with the which at present is uncertain. female RM sera was less marked, but a similar trend was
Could the presence of aCL in men be relevant to pregnancy evident, with two of the five positive sera and all of the outcome? Although it was a reasonable assumption that some borderline sera becoming negative. There was little difference autoimmune process operating in the women was harming apparent, however, with four SLE sera used for comparison. their pregnancies, autoimmunity has a genetic basis (Vyse and Under these modified assay conditions, the prevalence of anti- Todd, 1996) and it is possible that an aCL-related gene inherited cardiolipin antibodies (Ͼ20 GPL) in recurrent aborters, their by the fetus could be influential. Our limited information argues partners and the population of blood donors was found to be against this possibility. While our data support the findings of 1.7, 1.4 and 2.0% respectively.
others that maternal autoantibodies confer a poorer prognosis The same sera were analysed for relative activities towards amongst recurrent aborters (Gleicher, 1994) , the wives of the phospholipids other than cardiolipin. The outcomes are sumaCL-positive men did not present with a greater number of marized in Table IV . As expected, all four SLE sera displayed a previous miscarriages than the group as a whole, nor, amongst markedly higher activity towards phosphatidylserine compared the few who went on to conceive again, did they have more with phosphatidylcholine, whether untreated or heat-inactivated subsequent miscarriages than would be expected. FCS was used in the assay system. The sera from the male The aCL in our male partners have somewhat different partners of RM couples, however, were divided in their relative characteristics from the typical aCL found in SLE which have activities towards the two phospholipids when untreated FCS been reported to have a markedly higher activity towards was used, but showed a higher activity towards phosphotidylanionic phospholipids like phosphatidylserine compared with choline in the presence of heat-treated FCS. The sera of female RM patients were biased towards greater activity against zwitterionic phospholipids like phosphatidylcholine. Typically, Kilpatrick, D.C. (1994) transmitted between spouses must also be considered unlikely.
Received on October 11, 1996; accepted on January 7, 1997 Several groups have reported an association between aCL and HLA-DR4, HLA-DR7 or the supertypic specificity, HLA-DR53, although the literature in this area is inconsistent (Camps et al., 1995) . We have insufficient data to reach any conclusions, but conjecture that specific HLA alleles may be associated with particular populations of aCL.
In conclusion, aCL occur as commonly in the male partners of RM patients as in their wives. Within groups of aCLpositive subjects, however, there may be different mixtures of antibody populations, and further investigation is required to determine if such differences are relevant to clinical correlates or HLA associations.
